Converting 195 mg Oral Morphine to Oral Hydromorphone
For a patient on 195 mg total daily oral morphine, convert to approximately 26-39 mg total daily oral hydromorphone, starting at the lower end (26-29 mg/day) and dividing into doses every 4-6 hours for immediate-release formulations.
Conversion Calculation
Using the established equianalgesic conversion ratios from NCCN guidelines 1:
- Standard morphine:hydromorphone ratio is approximately 5:1 1
- 195 mg oral morphine ÷ 5 = 39 mg oral hydromorphone (equianalgesic dose)
However, you must reduce this calculated dose by 25-50% to account for incomplete cross-tolerance between opioids 1:
- 39 mg reduced by 25% = 29.25 mg/day
- 39 mg reduced by 50% = 19.5 mg/day
Recommended Starting Dose
Start with 26-29 mg total daily hydromorphone (approximately 33% reduction from equianalgesic dose) 2:
- For immediate-release: Divide into 4-6 mg every 4-6 hours (approximately 4-5 doses daily)
- This provides a conservative starting point that prioritizes safety over initial efficacy
The FDA label explicitly states: "It is safer to underestimate a patient's 24-hour hydromorphone dosage than to overestimate the 24-hour dosage and manage an adverse reaction due to overdose" 2.
Clinical Context for Dose Reduction
If pain was well-controlled on morphine: Use the 25-50% reduction (start at 19.5-29 mg/day) 1. This accounts for incomplete cross-tolerance and reduces risk of oversedation and respiratory depression.
If pain was poorly controlled on morphine: You may start with 100% of the equianalgesic dose (39 mg/day) or even increase by 25% (approximately 49 mg/day) 1. However, this requires close monitoring for the first 24-72 hours 2.
Titration Strategy
- Monitor closely for respiratory depression, especially within the first 24-72 hours 2
- Titrate upward every 24 hours if pain control is inadequate 1
- Provide breakthrough medication at 5-15% of total daily dose every 2 hours as needed 2
- Most patients achieve dose stabilization within 3-21 days, with 70% stabilizing in ≤2 titration steps 3, 4, 5
Supporting Evidence for 5:1 Ratio
The 5:1 conversion ratio (oral morphine to oral hydromorphone) is well-established 1:
- ESMO guidelines confirm oral morphine to oral hydromorphone ratio of 1:5 to 1:7.5 1
- Multiple clinical studies support the 5:1 ratio for conversion with good efficacy and tolerability 6, 3, 4, 5
- One recent study suggested the equipotency may be closer to 6.5:1, which would support even more conservative dosing 7
Critical Safety Considerations
Avoid morphine in renal failure due to accumulation of renally cleared metabolites 1. Hydromorphone may be preferred in this population, though dose reduction of 25-50% is still required 2.
Individual variability is substantial - interindividual pharmacokinetic variability ranges from 9-31% for both opioids 8. This underscores the importance of individualized titration after initial conversion.
Monitor for delayed effects - hydromorphone has faster onset but morphine has longer duration of respiratory depression 9. Peak respiratory depression occurs at 3.0 hours for hydromorphone vs 5.5 hours for morphine 9.